Prepared For

Ms Rama Devi
F 72
fa lse

Name Patient ID Gender Age

Ms Rama Devi 6881243 F 72

Health Summary

BLOOD COUNTS THYROID PROFILE

Everything looks good Everything looks good

LIPID PROFILE

DIABETES MONITORING
Test Name Result

HsCRP 5.68
Test Name Result
Total Cholesterol 260
HbA1c (Glycosylated Haemoglobin) 5.7
Triglycerides 153 Please Watchout
+ 3 tests Please Watchout

KIDNEY PROFILE

Test Name Result LIVER PROFILE

Serum Creatinine 0.5
Please Watchout Everything looks good

ELECTROLYTES
ANEMIA STUDIES
Everything looks good
Everything looks good

VITAMIN PROFILE

MINERAL PROFILE
Test Name Result

Vitamin D (25-Hydroxy) 24.37 Everything looks good

Please Watchout
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Whole blood EDTA Report Date : Jan 21, 2024, 04:48 PM
Barcode No : HX934333 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Advance Plus Full Body Checkup
Complete Blood Count (CBC)
RBC PARAMETERS
Hemoglobin 13.1 g/dL 12.0 - 15.0
Method : Cyanide free spectrophotometry.
RBC Count 4.6 10^6/µl 3.8 - 4.8
Method : Electrical impedance
PCV 39.4 % 36 - 46
Method : Calculated
MCV 85.8 fl 83 - 101
Method : Calculated
MCH 28.4 pg 27 - 32
Method : Calculated
MCHC 33.2 g/dL 31.5 - 34.5
Method : Calculated
RDW (CV) * 13.4 % 11.6 - 14.0
Method : Calculated
RDW-SD * 41.2 fl 35.1 - 43.9
Method : Calculated
WBC PARAMETERS
TLC 4.9 10^3/µl 4 - 10
Method : Electrical Impedence(Leishman stain)
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils 60 % 40-80
Method : Double hydrodynamic sequential system
Lymphocytes 33 % 20-40
Method : Double hydrodynamic sequential system
Monocytes 5 % 2-10
Method : Double hydrodynamic sequential system
Eosinophils 2 % 1-6
Method : Double hydrodynamic sequential system
Basophils * 0 % <2
Method : Double hydrodynamic sequential system
Absolute leukocyte counts
Method : calculated
Neutrophils. 2.94 10^3/µl 2-7
Lymphocytes. 1.62 10^3/µl 1-3
Monocytes. 0.25 10^3/µl 0.2 - 1.0
Eosinophils. 0.1 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 1 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Whole blood EDTA Report Date : Jan 21, 2024, 04:48 PM
Barcode No : HX934333 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

PLATELET PARAMETERS
Platelet Count * 244 10^3/µl 150 - 410
Method : Electrical impedance(Leishman stain)
Mean Platelet Volume (MPV) * 8.2 fL 9.3 - 12.1
Method : Calculated
PCT * 0.2 % 0.17 - 0.32
Method : Calculated
PDW * 13.8 fL 8.3 - 25.0
Method : Calculated
P-LCR 23.7 % 18 - 50
Method : Calculated
P-LCC 58 % 44 - 140
Method : Calculated
Mentzer Index * 18.65 % -

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 2 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Whole blood EDTA Report Date : Jan 21, 2024, 05:24 PM
Barcode No : HX934333 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Advance Plus Full Body Checkup
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 34 mm/hr 0 - 35
Method : MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

AGE MALE FEMALE

1 DAY 0-12 0-12
2 - 7 DAYS 0-4 0-4
8 - 14 DAYS 0-17 0-17
15 DAYS - 17 YEARS 0-20 0-20
18 - 50 YEARS 0-10 0-12
51- 60 YEARS 0-12 0-19
61 - 70 YEARS 0-14 0-20
71 - 100 YEARS 0-30 0-35

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 3 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Whole blood EDTA Report Date : Jan 21, 2024, 04:48 PM
Barcode No : HX934333 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Advance Plus Full Body Checkup
HbA1C (Glycosylated Haemoglobin)
GLYCOSYLATED HEMOGLOBIN (HbA1c) 5.7 % <5.7
Method : HPLC
ESTIMATED AVERAGE GLUCOSE * 116.89 mg/dL -
Method : calculated.

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 4 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Whole blood EDTA Report Date : Jan 21, 2024, 04:48 PM
Barcode No : HX934333 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 5 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : FLUORIDE F Report Date : Jan 21, 2024, 03:33 PM
Barcode No : ZB164553 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Glucose Fasting (BSF)
GLUCOSE FASTING 82 mg/dL 70 - 100
Method : Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 6 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Liver Function Test (LFT)
BILIRUBIN TOTAL 0.59 mg/dL 0.2 - 1.2
Method : diazonium salt
BILIRUBIN DIRECT * 0.21 mg/dL 0.0 - 0.5
Method : Diazo Reaction
BILIRUBIN INDIRECT * 0.38 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 16 U/L 5 - 34
Method : Enzymatic {NADH (without P5P)}
SGPT/ALT 13 U/L 0 to 55
Method : Enzymatic {NADH (without P5P)}
SGOT/SGPT Ratio * 1.23 - -
Method : calculated
ALKALINE PHOSPHATASE 74 U/L 40 - 150
Method : paranitrophenyl phosphate
TOTAL PROTEIN 6.6 g/dL 6.4 - 8.3
Method : Biuret
ALBUMIN 4.24 gm/dL 3.8 - 5.0
Method : BCG
GLOBULIN * 2.36 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
ALBUMIN : GLOBULIN RATIO * 1.8 - 1.0 - 2.1
Method : Calculation (Albumin/Globulin)
GAMMA GLUTAMYL TRANSFERASE (GGT) * 34 U/L 9 to 36
Method : Photometric

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and
performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or
destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes. Aspartate
aminotransferase (AST),SGOT: The AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is
almost exclusively found in the liver. If ALT and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase
and GGT: Another of the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline phosphatase Gamma-utamyl
transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is by far the most commonly tested of the three. If
alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile flow problems can be due to a problem in the liver, the gallbladder, or
the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood
contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your
immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition 4.agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen
in dehydration due to inadequate water intake or to excessive water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased
production of proteins Low albumin levels may be caused by: 1.A poor diet (malnutrition). 2.Kidney disease. 3.Liver disease. High albumin levels may be caused by:
Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 7 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Kidney Function Test (KFT)
BLOOD UREA * 28.24 mg/dL 18 - 55
Method : Calculated
CREATININE 0.5 mg/dL 0.57 - 1.11
Method : kinetic alkaline picrate
BUN 13.2 mg/dL 9.8 - 20.1
Method : Urease
BUN/CREATININE RATIO * 26.4
UREA / CREATININE RATIO * 56.48
URIC ACID 4.0 mg/dL 2.6 - 6.0
Method : Uricase
CALCIUM Serum 8.8 mg/dL 8.8 - 10.0
Method : Arsenazo III
PHOSPHORUS 3.2 mg/dL 2.3 - 4.7
Method : phosphomolybdate.
SODIUM 139 mmol/L 136 - 145
Method : Ion selective Electrode-Indirect.
POTASSIUM 3.7 mmol/L 3.5 - 5.1
Method : Ion selective Electrode-Indirect.
CHLORIDE 104 mmol/L 98 - 107
Method : Ion selective Electrode-Indirect.

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may
indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful
urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes
(sodium,potassium,and chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells
and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress
and treatment of these diseases.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 8 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Lipid Profile
TOTAL CHOLESTEROL 260 mg/dL Desirable : <200
Method : enzymatic CHOD-PAP Borderline : 200-239
High : >240
TRIGLYCERIDES 153 mg/dL Normal : <150
Method : Glycerol phosphate oxidase Borderline : 150-199
High : 200-499
Very high : >500
HDL CHOLESTEROL 44 mg/dL >40
Method : cholesterol oxidase and peroxidase
NON HDL CHOLESTEROL * 216 mg/dL <130
Method : Calculated
LDL CHOLESTEROL * 185.4 mg/dL Optimal <100
Method : Calculated Near optimal/above optimal
100-129 Borderline high
130-159
High 160-189
Very high >190
V.L.D.L CHOLESTEROL * 30.6 mg/dL < 30
Method : Calculated
CHOL/HDL Ratio * 5.91 - 3.5 - 5.0
Method : Calculated
HDL/ LDL RATIO * 0.24 - Desirable : 0.5 - 3.0
Method : Calculated
Borderline : 3.1 - 6.0

High : > 6.0

LDL/HDL Ratio * 4.21 -
Method : Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159

Borderline High 200-239 150-199 130-159 160 - 189

High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 9 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &

3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)
Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 10 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Iron Studies
IRON 58 µg/dL 50 - 170
Method : Ferrozine
TIBC,(Total Iron Binding Capacity) 310 µg/dL 250 - 450
Method : Calculated
UIBC 252 µg/dL 70 - 310
Method : Ferrozine
TRANSFERRIN SATURATION 18.71 % -
Method : Calculated

Interpretation:
Increased levels due to iron ingestion or ineffective erythropoiesis.Decreased levels due to infection, inflammation, malignancy, menstruation and
Fe deficiency.Needs to be taken into consideration with TIBC. Transferrin Saturation:- Low level Transferrin Saturation can indicate iron
deficiency, erythropoiesis, infection, or inflammation. High level Transferrin Saturation can indicate recent ingestion of dietary iron,ineffective
erythropoiesis,haemochromatosis or liver disease.High TIBC, UIBC, or transferrin usually indicates iron deficiency, but they are also increased in
pregnancy and with the use of oral contraceptives. Low TIBC, UIBC, or transferrin may occur if someone has:Hemochromatosis, Certain types of
anemia due to accumulated iron,Malnutrition,kidney disease that causes a loss of protein in urine.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 11 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
C-Reactive Protein (CRP), Quantitative
CRP (Quantitative) 5.5 mg/L up to 5
Method : Immunoturbidimetry

Interpretation:
The level of CRP in the blood is normally low.
Increased CRP level:

A high or increasing amount of CRP in the blood suggests the presence of inflammation but will not identify its location or the cause.
Suspected bacterial infection—a high CRP level can provide indication that patient has an infection.
Chronic inflammatory disease—high levels of CRP suggest a flare-up if you have a chronic inflammatory disease or that treatment has not
been effective.

If the CRP level is initially elevated and drops, it means that the inflammation or infection is subsiding and/or responding to treatment.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 12 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
High Sensitivity C-Reactive Protein (Hs-CRP)
HIGHLY SENSITIVE C-REACTIVE PROTEIN (hs- 5.68 mg/L Low < 1.00 mg/L
CRP)
Method : Particle enhanced immunoturbidimetric assay. Average 1.0-3.0 mg/L

High > 3.0 mg/L

Interpretation:
Note: To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and calculate the average

Comments
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a strongest predictor of future
coronary events. It reveals the risk of future Myocardial infarction and Stroke among healthy men and women, independent of traditional risk
factors. It identifies patients at risk of first Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events
also correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident Diabetes.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 13 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Rheumatoid Factor (RF), Quantitative
RHEUMATOID FACTOR, Quantitative < 20.0 IU/mL Negative <30
Method : Immunoturbidimetry Weakly positive 30 to 50
Positive >50
Interpretation:
Approximately 85% of patients with Rheumatoid arthritis have detectable RA. It may also be seen in other medical conditions like Sjogren’s
syndrome and SLE.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 14 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Vitamin B12 / Cyanocobalamin
Vitamin - B12 354 pg/mL 187 - 883
Method : CMIA

Interpretation:
Low Values are a sign of a vitamin B12 deficiency. People with this deficiency are likely to have or develop symptoms.
Causes of vitamin B12 deficiency include:Not enough vitamin B12 in diet (rare except with a strict vegetarian diet), Diseases that cause
malabsorption (for example, celiac disease and Crohn's disease), Lack of intrinsic factor, Above normal heat production (for example, with
hyperthyroidism), Pregnancy. Increased vitamin B12 levels are uncommon. Usually excess vitamin B12 is removed in the urine. Conditions that can
increase B12 levels include: Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders (for example, polycythemia vera and chronic
myelocytic leukemia).
Vitamin B12: Low Levels can cause malabsorption, Lack of intrinsic factor, Above normal heat production (for example, with hyperthyroidism),
Pregnancy.High Level Liver disease, Myeloproliferative disorders (for example, polycythemia vera and chronic myelocytic leukemia).
1. Out of 140 healthy indian population, 91% of Vitamin B 12 concentrations was at lower level: 59.00 pg/ml and upper level: 700.00 pg/ml

"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November 2017. With
individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 15 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Vitamin D 25 Hydroxy
Vitamin D 25 - Hydroxy 24.37 ng/mL Deficiency : <30 ng/mL
Method : CMIA

Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D deficiency
is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It is also used
for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 16 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 03:46 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Thyroid Profile Total
TRIIODOTHYRONINE ( T3 ) 88.0 ng/dL 35 - 193
Method : CMIA
TOTAL THYROXINE ( T4 ) 6.81 µg/dL 4.87 - 11.2
Method : CMIA
THYROID STIMULATING HORMONE (Ultrasensitive) 1.05 mIU/L 0.35 - 4.94
Method : CMIA

Interpretation:
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are
significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome,
multiple alterations in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI)
without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid Binding Globulin (TBG) concentrations remain relatively
constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids and glucocorticoids are known to alter
TBG levels and may cause false thyroid values for Total T3 and T4 tests.
TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone receptor decreases thyroid
Normal High High
hormone function)

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 17 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Serum Report Date : Jan 21, 2024, 04:36 PM
Barcode No : ZB164552 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Advance Plus Full Body Checkup
Immunoglobulin E (IgE Total)
IMMUNOGLOBULIN IgE TOTAL SERUM 21.99 IU/mL
Method : ECLIA

Interpretation:
REFERANCE Ranges Unit
Age group IU/mL
Neonates <1.5
Infants in 1st year of life <15
Children aged 1-5 years <60
Children aged 6-9 years <90
Children aged 10-15 years <200
Adults <100

The level of serum IgE rises during childhood and reaches adult levels during the teens. IgE is the mediator of the allergic response. Patients with
atopic disease, including allergic asthama, allergic rhinitis, and atopic dermatitis commonly have moderately elevated serum IgE levels. Total serum
IgE levels may also be elevated in the presence of some clinical conditions that are not related to allergy. These clinical conditions include parasitic
infections, immunodeficiency states, autoimmune diseases, Hodgkins disease, bronchopulmonary aspergillosis, IgE myeloma, and Sezary
syndrome.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 18 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Spot Urine Report Date : Jan 21, 2024, 03:33 PM
Barcode No : YA153676 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

CLINICAL PATHOLOGY REPORT

Advance Plus Full Body Checkup
Urine Routine and Microscopic Examination
PHYSICAL EXAMINATON
Volume * 20 mL
Method : visual
Colour * Pale yellow Pale yellow
Method : visual
Transparency * Clear Clear
Method : visual
Deposit * Absent Absent
Method : visual
CHEMICAL EXAMINATION
Reaction (pH) 6.0 5.5-8.0
Method : Double Indicator
Specific Gravity 1.010 0 1.010 - 1.030
Method : Ion Exchange.
Urine Glucose (sugar) Negative Negative
Method : Oxidase / Peroxidase
Urine Protein (Albumin) Negative Negative
Method : bromophenol blue
Urine Ketones (Acetone) Negative Negative
Method : Legals Test
Blood Negative Negative
Method : Peroxidase Hemoglobin
Leucocyte esterase Negative Negative
Method : amino acid aster
Bilirubin Urine Negative Negative
Method : Diazotized dicholoroaniline
Nitrite Negative Negative
Method : Griless Test
Urobilinogen Normal Normal
Method : Ehrlichs Test
MICROSCOPIC EXAMINATION
Pus Cells (WBCs) * 2-4 /hpf 0-5
Method : WET MOUNT
Epithelial Cells * 3-5 /hpf 0-4
Method : WET MOUNT
Red blood Cells * Absent /hpf Absent
Method : WET MOUNT
Crystals * Absent Absent
Method : WET MOUNT

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 19 of 20
 Patient Name : Ms Rama Devi
DOB/Age/Gender : 72 Y/Female Bill Date : Jan 20, 2024, 11:11 AM
Patient ID / UHID : 6881243/RCL5975825 Sample Collected : Jan 21, 2024, 07:51 AM
Referred By : Dr. Sample Received : Jan 21, 2024, 02:03 PM
Sample Type : Spot Urine Report Date : Jan 21, 2024, 03:33 PM
Barcode No : YA153676 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

Cast * Absent Absent
Method : WET MOUNT
Yeast Cells * Absent Absent
Method : WET MOUNT
Amorphous deposits * Absent Absent
Method : WET MOUNT
Bacteria * Absent Absent
Method : WET MOUNT
Protozoa * Absent Absent
Method : WET MOUNT

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection - Bengaluru

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Building No.168,First Floor Sarathy,9 Main Sector 6 HRS Layout, Bangalore 560102

Page 20 of 20
 Terms and Conditions of Reporting

1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.

2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.

3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.

4. This report shall not be deemed valid or admissible for any medico-legal purposes.

5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
 Name Patient ID Gender Age
fa lse

Ms Rama Devi 6881243 F 72

Health Advisory
Normal (N) Low (L) Borderline (BL) High (H)

Vitamins Profile
Vitamins are considered essential nutrients because they perform hundreds of roles in your body. They help
maintain bones, heal wounds, and strengthen your immune system. They also convert food into energy, and repair
cellular damage

Vitamin D (25-Hydroxy): 24.37 ng/mL BORDERLINE

VERY LOW LOW NORMAL HIGH

< 20 20 - 30 30 - 100 > 100

You: 24.37

Diet and Lifestyle Tips :

Avoid very high-SPF sunscreen: Your

skin naturally produces vitamin D on
being exposed to sun but applying Consider supplements. Ask your doctor
sunscreen on your skin can decrease if Vitamin D supplements are right for
this natural production. It is you.
recommended that you should get a
balanced amount of sunshine.

About Diabetes
This panel is used to check how much glucose/sugar there is in your blood. Too much blood glucose might
indicate diabetes.

HbA1c (Glycosylated Haemoglobin): 5.7% HIGH

NORMAL HIGH

< 5.6 > 5.6

You: 5.7

One of the ways to control and reduce your HbA1c level - is to change your diet. Generally, foods that are high in carbs increase
your blood sugar significantly. Also, foods that are high in fiber keep your glucose level in check.
Additionally, keeping your portion sizes small could prevent sharp rises in your blood sugar.

Some high-Carb foods to avoid Some high-Fiber foods to choose from

WHITE BREAD POTATOES APPLES CABBAGE

 Lipid Profile
fa lse

This panel measures the amount of lipoprotein - a type of fat required to produce energy in your body. Too much fat
restricts oxygen ow to your heart, which may lead to heart disease.

Total Cholesterol: 260 mg/dL HIGH

NORMAL BORDERLINE HIGH

< 200 200-240 > 240

You: 260

Diet and Lifestyle Tips :

Regular aerobic exercise and weight loss

Eat a low-salt diet that emphasizes fruits,
(if obese) can bring your cholesterol
vegetables and whole grains.
levels in the normal healthy range.

Triglycerides: 153 mg/dL HIGH

NORMAL HIGH

< 150 > 150

You: 153

Complications :

High value: May contribute to hardening of

the arteries or thickening of the artery walls Extremely high triglycerides can also cause
(arteriosclerosis) — which increases the acute inflammation of the pancreas
risk of stroke, heart attack and heart (pancreatitis).
disease.

Diet and Lifestyle Tips :

Exercise regularly. Aim for at least 30

minutes of physical activity on most or all
days of the week. Try to incorporate more
Avoid sugar and refined carbohydrates.
physical activity into your daily tasks —
for example, climb the stairs at work or
take a walk during breaks.

Limit how much alcohol you drink.

Lose weight. If you have mild to moderate
Alcohol has a particularly potent effect
hypertriglyceridemia, focus on cutting
on triglycerides. If you have severe
calories. Extra calories are converted to
hypertriglyceridemia, avoid drinking any
triglycerides and stored as fat.
alcohol.
+ +
SMART HEALTH REPORT
RT
MC-5280

About Redcliffe Labs

We
Weare
are
India’s
India’sMost
Most Trusted
Trusted &&Fastest
FastestGrowing
GrowingNetwork
Networkof Diagnostic
of Diagnostics
Centres
Labs

Best Customer Quality Commitment Affordable Prices

+
Experience With Accurate Reports With Quick Results

Commitment to excellence, Focus on quality with Value for money with

high end technology oriented staff accurate results quick turn around time (TAT)

Select from a wide range of

Full Body Health Check-up

packages that suits your health

Best Selling Package

Advance Full Body Check-up

Download our app & get

Free report consultation

A Simple and easy way to track your health

3500 + Tests & Packages Home Sample Collection or Visit

Nearest Collection Centre

Access Smart Reports Presence in 150+ Cities